Modified Vaccinia Virus Ankara-Based Vaccine Vectors Induce Apoptosis in Dendritic Cells Draining from the Skin via both the Extrinsic and Intrinsic Caspase Pathways, Preventing Efficient Antigen Presentation

被引:31
作者
Guzman, E. [1 ]
Cubillos-Zapata, C. [1 ]
Cottingham, M. G. [2 ]
Gilbert, S. C. [2 ]
Prentice, H. [1 ]
Charleston, B. [1 ]
Hope, J. C. [1 ]
机构
[1] AFRC, Inst Anim Hlth, Newbury RG16 0NN, Berks, England
[2] Univ Oxford, Jenner Inst, Oxford, England
基金
英国生物技术与生命科学研究理事会;
关键词
IMMUNOGENICITY IN-VIVO; AFFERENT LYMPH; T-CELLS; MYCOBACTERIUM-BOVIS; CROSS-PRESENTATION; WORKSHOP FINDINGS; PRESENTING CELLS; GAG VACCINE; HIV-1; GAG; RESPONSES;
D O I
10.1128/JVI.00264-12
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Dendritic cells (DC) are potent antigen-presenting cells and central to the induction of immune responses following infection or vaccination. The collection of DC migrating from peripheral tissues by cannulation of the afferent lymphatic vessels provides DC which can be used directly ex vivo without extensive in vitro manipulations. We have previously used bovine migrating DC to show that recombinant human adenovirus 5 vectors efficiently transduce afferent lymph migrating DEC-205(+) CD11c(+) CD8(-) DC (ALDC). We have also shown that recombinant modified vaccinia virus Ankara (MVA) infects ALDC in vitro, causing downregulation of costimulatory molecules, apoptosis, and cell death. We now show that in the bovine system, modified vaccinia virus Ankara-induced apoptosis in DC draining from the skin occurs soon after virus binding via the caspase 8 pathway and is not associated with viral gene expression. We also show that after virus entry, the caspase 9 pathway cascade is initiated. The magnitude of T cell responses to mycobacterial antigen 85A (Ag85A) expressed by recombinant MVA-infected ALDC is increased by blocking caspase-induced apoptosis. Apoptotic bodies generated by recombinant MVA (rMVA)-Ag85A-infected ALDC and containing Ag85A were phagocytosed by noninfected migrating ALDC expressing SIRP alpha via actin-dependent phagocytosis, and these ALDC in turn presented antigen. However, the addition of fresh ALDC to MVA-infected cultures did not improve on the magnitude of the T cell responses; in contrast, these noninfected DC showed downregulation of major histocompatibility complex class II (MHC-II), CD40, CD80, and CD86. We also observed that MVA-infected ALDC promoted migration of DEC-205(+) SIRP alpha(+) CD21(+) DC as well as CD4(+) and CD8(+) T cells independently of caspase activation. These in vitro studies show that induction of apoptosis in DC by MVA vectors is detrimental to the subsequent induction of T cell responses.
引用
收藏
页码:5452 / 5466
页数:15
相关论文
共 86 条
[1]   Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge [J].
Antonis, Adriaan F. G. ;
van der Most, Robbert G. ;
Suezer, Yasemin ;
Stockhofe-Zurwieden, Norbert ;
Daus, Franz ;
Sutter, Gerd ;
Schrijver, Remco S. .
VACCINE, 2007, 25 (25) :4818-4827
[2]   Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction [J].
Behboudi, S ;
Moore, A ;
Gilbert, SC ;
Nicoll, CL ;
Hill, AVS .
VACCINE, 2004, 22 (31-32) :4326-4331
[3]   Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection [J].
Betts, MR ;
Exley, B ;
Price, DA ;
Bansal, A ;
Camacho, ZT ;
Teaberry, V ;
West, SM ;
Ambrozak, DR ;
Tomaras, G ;
Roederer, M ;
Kilby, JM ;
Tartaglia, J ;
Belshe, R ;
Gao, F ;
Douek, DC ;
Weinhold, KJ ;
Koup, RA ;
Goepfert, P ;
Ferrari, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (12) :4512-4517
[4]   Preclinical Studies of a Modified Vaccinia Virus Ankara-Based HIV Candidate Vaccine: Antigen Presentation and Antiviral Effect [J].
Brandler, Samantha ;
Lepelley, Alice ;
Desdouits, Marion ;
Guivel-Benhassine, Florence ;
Ceccaldi, Pierre-Emmanuel ;
Levy, Yves ;
Schwartz, Olivier ;
Moris, Arnaud .
JOURNAL OF VIROLOGY, 2010, 84 (10) :5314-5328
[5]  
Brooke GP, 1998, EUR J IMMUNOL, V28, P1, DOI 10.1002/(SICI)1521-4141(199801)28:01<1::AID-IMMU1>3.0.CO
[6]  
2-V
[7]   Lymphocyte homing and homeostasis [J].
Butcher, EC ;
Picker, LJ .
SCIENCE, 1996, 272 (5258) :60-66
[8]   Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: A murine tumor model [J].
Carroll, MW ;
Overwijk, WW ;
Chamberlain, RS ;
Rosenberg, SA ;
Moss, B ;
Restifo, NP .
VACCINE, 1997, 15 (04) :387-394
[9]   A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis [J].
Carson, Connor ;
Antoniou, Maria ;
Ruiz-Argueello, Maria Begona ;
Alcami, Antonio ;
Christodoulou, Vasiliki ;
Messaritakis, Ippokratis ;
Blackwell, Jenefer M. ;
Courtenay, Orin .
VACCINE, 2009, 27 (07) :1080-1086
[10]   Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene [J].
Casimiro, DR ;
Chen, L ;
Fu, TM ;
Evans, RK ;
Caulfield, MJ ;
Davies, ME ;
Tang, A ;
Chen, MC ;
Huang, LY ;
Harris, V ;
Freed, DC ;
Wilson, KA ;
Dubey, S ;
Zhu, DM ;
Nawrocki, D ;
Mach, H ;
Troutman, R ;
Isopi, L ;
Williams, D ;
Hurni, W ;
Xu, Z ;
Smith, JG ;
Wang, S ;
Liu, X ;
Guan, LM ;
Long, R ;
Trigona, W ;
Heidecker, GJ ;
Perry, HC ;
Persaud, N ;
Toner, TJ ;
Su, Q ;
Liang, XP ;
Youil, R ;
Chastain, M ;
Bell, AJ ;
Volkin, DB ;
Emini, EA ;
Shiver, JW .
JOURNAL OF VIROLOGY, 2003, 77 (11) :6305-6313